vs

Side-by-side financial comparison of Iridium Communications Inc. (IRDM) and LivaNova PLC (LIVN). Click either name above to swap in a different company.

LivaNova PLC is the larger business by last-quarter revenue ($360.9M vs $219.1M, roughly 1.6× Iridium Communications Inc.). Iridium Communications Inc. runs the higher net margin — 9.9% vs 8.6%, a 1.3% gap on every dollar of revenue. On growth, LivaNova PLC posted the faster year-over-year revenue change (12.1% vs 1.9%). Over the past eight quarters, LivaNova PLC's revenue compounded faster (10.6% CAGR vs 4.4%).

Iridium Communications Inc. is a publicly traded American company headquartered in McLean, Virginia, United States. Iridium operates the Iridium satellite constellation, a system of 80 satellites: 66 are active satellites and the remaining fourteen function as in-orbit spares. Iridium Satellites are used for worldwide voice and data communication from handheld satellite phones, satellite messenger communication devices and integrated transceivers, as well as for two-way satellite messaging se...

LivaNova, plc is an American medical device manufacturer based in the UK. The company develops devices used for cardiac surgery and neuromodulation. The company was formed in 2015 by a $2.7B merger between Houston, Texas-based Cyberonics, Inc. and Milan, Italy-based Sorin S.p.a. The company trades on the NASDAQ stock exchange under the ticker symbol "LIVN".

IRDM vs LIVN — Head-to-Head

Bigger by revenue
LIVN
LIVN
1.6× larger
LIVN
$360.9M
$219.1M
IRDM
Growing faster (revenue YoY)
LIVN
LIVN
+10.2% gap
LIVN
12.1%
1.9%
IRDM
Higher net margin
IRDM
IRDM
1.3% more per $
IRDM
9.9%
8.6%
LIVN
Faster 2-yr revenue CAGR
LIVN
LIVN
Annualised
LIVN
10.6%
4.4%
IRDM

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
IRDM
IRDM
LIVN
LIVN
Revenue
$219.1M
$360.9M
Net Profit
$21.6M
$30.9M
Gross Margin
65.2%
Operating Margin
23.2%
11.8%
Net Margin
9.9%
8.6%
Revenue YoY
1.9%
12.1%
Net Profit YoY
-44.7%
EPS (diluted)
$0.57

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRDM
IRDM
LIVN
LIVN
Q1 26
$219.1M
Q4 25
$212.9M
$360.9M
Q3 25
$226.9M
$357.8M
Q2 25
$216.9M
$352.5M
Q1 25
$214.9M
$316.9M
Q4 24
$213.0M
$321.8M
Q3 24
$212.8M
$318.1M
Q2 24
$201.1M
$318.6M
Net Profit
IRDM
IRDM
LIVN
LIVN
Q1 26
$21.6M
Q4 25
$24.9M
$30.9M
Q3 25
$37.1M
$26.8M
Q2 25
$22.0M
$27.2M
Q1 25
$30.4M
$-327.3M
Q4 24
$36.3M
$55.9M
Q3 24
$24.4M
$33.0M
Q2 24
$32.3M
$16.3M
Gross Margin
IRDM
IRDM
LIVN
LIVN
Q1 26
Q4 25
65.2%
Q3 25
68.4%
Q2 25
67.8%
Q1 25
69.7%
Q4 24
68.2%
Q3 24
70.8%
Q2 24
68.7%
Operating Margin
IRDM
IRDM
LIVN
LIVN
Q1 26
23.2%
Q4 25
25.9%
11.8%
Q3 25
30.9%
15.1%
Q2 25
23.2%
15.4%
Q1 25
28.1%
15.3%
Q4 24
24.5%
11.5%
Q3 24
25.8%
11.2%
Q2 24
21.7%
12.6%
Net Margin
IRDM
IRDM
LIVN
LIVN
Q1 26
9.9%
Q4 25
11.7%
8.6%
Q3 25
16.4%
7.5%
Q2 25
10.1%
7.7%
Q1 25
14.2%
-103.3%
Q4 24
17.1%
17.4%
Q3 24
11.5%
10.4%
Q2 24
16.1%
5.1%
EPS (diluted)
IRDM
IRDM
LIVN
LIVN
Q1 26
Q4 25
$0.24
$0.57
Q3 25
$0.35
$0.49
Q2 25
$0.20
$0.50
Q1 25
$0.27
$-6.01
Q4 24
$0.30
$1.04
Q3 24
$0.21
$0.60
Q2 24
$0.27
$0.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRDM
IRDM
LIVN
LIVN
Cash + ST InvestmentsLiquidity on hand
$635.6M
Total DebtLower is stronger
$376.1M
Stockholders' EquityBook value
$1.2B
Total Assets
$2.6B
Debt / EquityLower = less leverage
0.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRDM
IRDM
LIVN
LIVN
Q1 26
Q4 25
$96.5M
$635.6M
Q3 25
$88.5M
$646.1M
Q2 25
$79.3M
$593.6M
Q1 25
$50.9M
$738.4M
Q4 24
$93.5M
$428.9M
Q3 24
$159.6M
$346.4M
Q2 24
$63.5M
$329.2M
Total Debt
IRDM
IRDM
LIVN
LIVN
Q1 26
Q4 25
$1.8B
$376.1M
Q3 25
$434.5M
Q2 25
$430.6M
Q1 25
$628.2M
Q4 24
$1.8B
$627.0M
Q3 24
$625.5M
Q2 24
$624.5M
Stockholders' Equity
IRDM
IRDM
LIVN
LIVN
Q1 26
Q4 25
$462.6M
$1.2B
Q3 25
$450.5M
$1.2B
Q2 25
$473.6M
$1.1B
Q1 25
$518.4M
$1.0B
Q4 24
$576.6M
$1.3B
Q3 24
$663.8M
$1.3B
Q2 24
$786.7M
$1.2B
Total Assets
IRDM
IRDM
LIVN
LIVN
Q1 26
Q4 25
$2.5B
$2.6B
Q3 25
$2.6B
$2.6B
Q2 25
$2.6B
$2.5B
Q1 25
$2.6B
$2.6B
Q4 24
$2.7B
$2.5B
Q3 24
$2.8B
$2.5B
Q2 24
$2.7B
$2.5B
Debt / Equity
IRDM
IRDM
LIVN
LIVN
Q1 26
Q4 25
3.80×
0.31×
Q3 25
0.38×
Q2 25
0.38×
Q1 25
0.61×
Q4 24
3.05×
0.47×
Q3 24
0.48×
Q2 24
0.50×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRDM
IRDM
LIVN
LIVN
Operating Cash FlowLast quarter
$82.4M
Free Cash FlowOCF − Capex
$50.2M
FCF MarginFCF / Revenue
13.9%
Capex IntensityCapex / Revenue
13.7%
8.9%
Cash ConversionOCF / Net Profit
2.67×
TTM Free Cash FlowTrailing 4 quarters
$173.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRDM
IRDM
LIVN
LIVN
Q1 26
Q4 25
$108.6M
$82.4M
Q3 25
$100.8M
$85.1M
Q2 25
$129.6M
$62.9M
Q1 25
$61.1M
$24.0M
Q4 24
$104.8M
$78.7M
Q3 24
$118.6M
$51.0M
Q2 24
$81.1M
$43.4M
Free Cash Flow
IRDM
IRDM
LIVN
LIVN
Q1 26
Q4 25
$75.1M
$50.2M
Q3 25
$79.2M
$62.2M
Q2 25
$108.9M
$47.8M
Q1 25
$36.5M
$13.2M
Q4 24
$80.5M
$68.3M
Q3 24
$100.0M
$32.8M
Q2 24
$68.7M
$31.2M
FCF Margin
IRDM
IRDM
LIVN
LIVN
Q1 26
Q4 25
35.3%
13.9%
Q3 25
34.9%
17.4%
Q2 25
50.2%
13.6%
Q1 25
17.0%
4.2%
Q4 24
37.8%
21.2%
Q3 24
47.0%
10.3%
Q2 24
34.2%
9.8%
Capex Intensity
IRDM
IRDM
LIVN
LIVN
Q1 26
13.7%
Q4 25
15.7%
8.9%
Q3 25
9.5%
6.4%
Q2 25
9.5%
4.3%
Q1 25
11.4%
3.4%
Q4 24
11.4%
3.2%
Q3 24
8.7%
5.7%
Q2 24
6.2%
3.8%
Cash Conversion
IRDM
IRDM
LIVN
LIVN
Q1 26
Q4 25
4.37×
2.67×
Q3 25
2.71×
3.18×
Q2 25
5.90×
2.32×
Q1 25
2.01×
Q4 24
2.88×
1.41×
Q3 24
4.85×
1.55×
Q2 24
2.51×
2.65×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IRDM
IRDM

Voice and data$57.4M26%
IoT data (2)$46.0M21%
Government$39.5M18%
Government service revenue (5)$27.6M13%
Subscriber equipment$20.2M9%
Hosted payload and other data service (4)$14.8M7%
Broadband (3)$12.2M6%
Commercial$1.3M1%

LIVN
LIVN

Other$169.4M47%
Neuromodulation Segment$119.7M33%
Cardiopulmonary Segment$71.8M20%

Related Comparisons